Health
Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy – News-Medical.net
Osimertinib was the first drug to be approved for adjuvant treatment after complete tumour resection in adults with stage IB…
Osimertinib was the first drug to be approved for adjuvant treatment after complete tumour resection in adults with stage IB to IIIA non-small cell lung cancer (NSCLC). In an early benefit assessment, the German Institute for Quality and Efficiency in Health…
Continue Reading
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News14 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business21 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!
-
Noosa News14 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years